CD44 and neoplasm: Local administration of the SF hydrogel containing PTX and Sal-loaded SF-nanoparticles (18 and 4 mg/kg of PTX and Sal, respectively) in subcutaneous murine hepatic cancer (H22) models showed significant results in terms of the reduction in the relative tumor volume, the animal survival rate and the inhibition of CD44+CD133+ stem cell spreading.